18 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Sep 2031. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Sep 2031
Next term end
9
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Sep 2031 · Medium confidence
Also notable
Ends May 2035 · High confidence
Also notable
Ends Nov 2035 · High confidence
Expandable Amnion Membrane for Treating Non-Healing Wounds
US 10,517,902
The most cited patent in this portfolio, cited by 21 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2031.
Placental Membrane Preparations and Methods of Making and Using Same for Regenerating Cartilage and Spinal Intervertebral Discs
US 11,083,758
Cited by 14 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2035.
Visco-Supplement Compositions, and Methods of Use Thereof
US 11,491,190
Granted 2022. Computed term ends 2035.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jun 30, 2027The maintenance fee for Expandable Amnion Membrane for Treating Non-Healing Wounds (US 10,517,902) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Aug 13, 2027The maintenance fee for Visco-Supplement Compositions, and Methods of Use Thereof (US 11,896,623) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
- 1 fee due Sep 3, 2027The maintenance fee for Methods of Treating Joint Diseases, Disorders, and Conditions with Tissue Inhibitors of Matrix Metalloproteinases (US 10,576,107) comes due Sep 3, 2027. Unpaid by Mar 3, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 5 largest of its 9 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Visco-Supplement Compositions, and Methods of Use Thereof | 3 in force | to Oct 2036 |
| Methods of Treating Joint Diseases, Disorders, and Conditions with Tissue Inhibitors of Matrix Metalloproteinases | 3 in force | to Aug 2036 |
| Osteoconductive Implants and Methods of Using Same | 3 in force | to Jun 2032 |
| Methods of Treating Chronic Wounds with Amniotic Fluid Having Elevated Levels of Tissue Inhibitors of Matrix Metalloproteinases | 2 in force | to Mar 2038 |
| Method and Composition for Hypothermic Storage of Placental Tissue | 2 in force | to Oct 2035 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,517,902 | Expandable Amnion Membrane for Treating Non-Healing Wounds In force · Medium confidence | In force | Medium confidence | |
| US 9,486,316 | Osteoconductive Implants and Methods of Using Same In force · High confidence | In force | High confidence | |
| US 9,539,104 | Osteoconductive Implants and Methods of Using Same In force · High confidence | In force | High confidence | |
| US 9,616,093 | Placental Membrane Preparation and Methods of Making and Using Same In force · Medium confidence | In force | Medium confidence | |
| US 9,511,119 | Preparations Containing Hepatocyte Growth Factor and Hyaluronic Acid and Methods of Making and Using Same In force · High confidence | In force | High confidence | |
| US 10,279,075 | Preparations Containing Hepatocyte Growth Factor and Hyaluronic Acid, and Methods of Making and Using Same In force · Low confidence | In force | Low confidence | |
| US 9,700,585 | Multipotent Prenatal Stem Cells In force · High confidence | In force | High confidence | |
| US 12,150,445 | Method and Composition for Hypothermic Storage of Placental Tissue In force · High confidence | In force | High confidence | |
| US 11,083,758 | Placental Membrane Preparations and Methods of Making and Using Same for Regenerating Cartilage and Spinal Intervertebral Discs In force · High confidence | In force | High confidence | |
| US 12,501,893 | Method and Composition for Hypothermic Storage of Placental Tissue In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 18: 4 applications pending · 7 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.